Detailed information for compound 1471925

Basic information

Technical information
  • TDR Targets ID: 1471925
  • Name: 3-(4-chlorophenyl)-2-methylsulfanylquinazolin -4-one
  • MW: 302.779 | Formula: C15H11ClN2OS
  • H donors: 0 H acceptors: 1 LogP: 4 Rotable bonds: 2
    Rule of 5 violations (Lipinski): 1
  • SMILES: CSc1nc2ccccc2c(=O)n1c1ccc(cc1)Cl
  • InChi: 1S/C15H11ClN2OS/c1-20-15-17-13-5-3-2-4-12(13)14(19)18(15)11-8-6-10(16)7-9-11/h2-9H,1H3
  • InChiKey: NPKBVVPMTHXHPW-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 3-(4-chlorophenyl)-2-methylsulfanyl-quinazolin-4-one
  • 3-(4-chlorophenyl)-2-(methylthio)-4-quinazolinone
  • 3-(4-chlorophenyl)-2-(methylthio)quinazolin-4-one
  • ZINC08188315

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Schistosoma mansoni sodium-bile acid cotransporter related 0.104 1 1
Onchocerca volvulus 0.104 1 0.5
Echinococcus granulosus sodium bile acid cotransporter 0.104 1 0.5
Echinococcus multilocularis sodium bile acid cotransporter 0.104 1 0.5
Echinococcus granulosus sodium bile acid cotransporter 0.104 1 0.5
Echinococcus multilocularis sodium bile acid cotransporter 0.104 1 0.5
Echinococcus multilocularis sodium bile acid cotransporter 0.104 1 0.5
Echinococcus granulosus sodium bile acid cotransporter 0.104 1 0.5
Loa Loa (eye worm) hypothetical protein 0.104 1 0.5

Activities

Activity type Activity value Assay description Source Reference
GI (functional) = 30 % Growth inhibition of human A549 cells at 10 uM after 48 hrs by coulter counter method ChEMBL. 21051122
GI (functional) = 30 % Growth inhibition of human HOP92 cells at 10 uM after 48 hrs by coulter counter method ChEMBL. 21051122
GI (functional) = 30 % Growth inhibition of human NCI-H226 cells at 10 uM after 48 hrs by coulter counter method ChEMBL. 21051122
GI (functional) = 30 % Growth inhibition of human NCI-H23 cells at 10 uM after 48 hrs by coulter counter method ChEMBL. 21051122
GI (functional) = 30 % Growth inhibition of human NCI-H522 cells at 10 uM after 48 hrs by coulter counter method ChEMBL. 21051122
GI (functional) = 30 % Growth inhibition of human COLO205 cells at 10 uM after 48 hrs by coulter counter method ChEMBL. 21051122
GI (functional) = 30 % Growth inhibition of human HCT116 cells at 10 uM after 48 hrs by coulter counter method ChEMBL. 21051122
GI (functional) = 30 % Growth inhibition of human KM12 cells at 10 uM after 48 hrs by coulter counter method ChEMBL. 21051122
GI (functional) = 30 % Growth inhibition of human SF268 cells at 10 uM after 48 hrs by coulter counter method ChEMBL. 21051122
GI (functional) = 30 % Growth inhibition of human SF539 cells at 10 uM after 48 hrs by coulter counter method ChEMBL. 21051122
GI (functional) = 30 % Growth inhibition of human SNB75 cells at 10 uM after 48 hrs by coulter counter method ChEMBL. 21051122
GI (functional) = 30 % Growth inhibition of human U251 cells at 10 uM after 48 hrs by coulter counter method ChEMBL. 21051122
GI (functional) = 30 % Growth inhibition of human M14 cells at 10 uM after 48 hrs by coulter counter method ChEMBL. 21051122
GI (functional) = 30 % Growth inhibition of human SK-MEL-2 cells at 10 uM after 48 hrs by coulter counter method ChEMBL. 21051122
GI (functional) = 30 % Growth inhibition of human SK-MEL-28 cells at 10 uM after 48 hrs by coulter counter method ChEMBL. 21051122
GI (functional) = 30 % Growth inhibition of human UACC62 cells at 10 uM after 48 hrs by coulter counter method ChEMBL. 21051122
GI (functional) = 30 % Growth inhibition of human IGROV1 cells at 10 uM after 48 hrs by coulter counter method ChEMBL. 21051122
GI (functional) = 30 % Growth inhibition of human OVCAR4 cells at 10 uM after 48 hrs by coulter counter method ChEMBL. 21051122
GI (functional) = 30 % Growth inhibition of human OVCAR8 cells at 10 uM after 48 hrs by coulter counter method ChEMBL. 21051122
GI (functional) = 30 % Growth inhibition of human SKOV3 cells at 10 uM after 48 hrs by coulter counter method ChEMBL. 21051122
GI (functional) = 30 % Growth inhibition of human 786-0 cells at 10 uM after 48 hrs by coulter counter method ChEMBL. 21051122
GI (functional) = 30 % Growth inhibition of human Caki1 cells at 10 uM after 48 hrs by coulter counter method ChEMBL. 21051122
GI (functional) = 30 % Growth inhibition of human SN12C cells at 10 uM after 48 hrs by coulter counter method ChEMBL. 21051122
GI (functional) = 30 % Growth inhibition of human UO31 cells at 10 uM after 48 hrs by coulter counter method ChEMBL. 21051122
GI (functional) = 30 % Growth inhibition of human MCF7 cells at 10 uM after 48 hrs by coulter counter method ChEMBL. 21051122
GI (functional) = 30 % Growth inhibition of human MDA-MB-231 cells at 10 uM after 48 hrs by coulter counter method ChEMBL. 21051122
GI (functional) = 30 % Growth inhibition of human MDA-MB-468 cells at 10 uM after 48 hrs by coulter counter method ChEMBL. 21051122
GI (functional) = 31.4 % Growth inhibition of human MOLT4 cells at 10 uM after 48 hrs by coulter counter method ChEMBL. 21051122
GI (functional) = 32 % Growth inhibition of human HL-60(TB) cells at 10 uM after 48 hrs by coulter counter method ChEMBL. 21051122
GI (functional) = 44.1 % Growth inhibition of human K562 cells at 10 uM after 48 hrs by coulter counter method ChEMBL. 21051122
GI (functional) = 47 % Growth inhibition of human T47D cells at 10 uM after 48 hrs by coulter counter method ChEMBL. 21051122
GI (functional) = 50.3 % Growth inhibition of human PC3 cells at 10 uM after 48 hrs by coulter counter method ChEMBL. 21051122

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.